advertisement

Topcon

Alves M 10

Showing records 1 to 10 | Display all abstracts from Alves M

85089 Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Mylla Boso AL
Clinical Ophthalmology 2020; 14: 103-111
85047 Ocular involvement in systemic lupus erythematosus patients: a paradigm shift based on the experience of a tertiary referral center
Dias-Santos A; Tavares Ferreira J
Lupus 2020; 29: 283-289
85089 Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Gasperi E
Clinical Ophthalmology 2020; 14: 103-111
85047 Ocular involvement in systemic lupus erythematosus patients: a paradigm shift based on the experience of a tertiary referral center
Pinheiro S
Lupus 2020; 29: 283-289
85089 Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Fernandes L
Clinical Ophthalmology 2020; 14: 103-111
85047 Ocular involvement in systemic lupus erythematosus patients: a paradigm shift based on the experience of a tertiary referral center
Cunha JP
Lupus 2020; 29: 283-289
85089 Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Costa VP
Clinical Ophthalmology 2020; 14: 103-111
85047 Ocular involvement in systemic lupus erythematosus patients: a paradigm shift based on the experience of a tertiary referral center
Alves M
Lupus 2020; 29: 283-289
85089 Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Alves M
Clinical Ophthalmology 2020; 14: 103-111
85047 Ocular involvement in systemic lupus erythematosus patients: a paradigm shift based on the experience of a tertiary referral center
Papoila AL; Moraes-Fontes MF; Proença R
Lupus 2020; 29: 283-289

Issue 21-1

Change Issue


advertisement

Topcon